JTB SRATEGIES

Lobbying for MANAX RUTSON CLINICAL DEVELOPMENT LLC · Healthcare Private Equity

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New York · $30,000.00 income · posted Nov 6, 2025

Lobbying activity 1

Health Issues

Rare disease drug development reciprocity across trusted nations.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem